To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases

被引:11
|
作者
Onishi, Iichiroh [1 ]
Yamamoto, Kouhei [1 ]
Kinowaki, Yuko [1 ]
Kitagawa, Masanobu [1 ]
Kurata, Morito [1 ]
机构
[1] Tokyo Med & Dent Univ, Grad Sch Med, Dept Comprehens Pathol, Tokyo 1138510, Japan
关键词
CRISPR screening; synthetic lethality; database; SCALE CRISPR-CAS9 KNOCKOUT; SYNTHETIC LETHAL; TRANSCRIPTIONAL ACTIVATION; CELL-DEATH; GENOME; GENES; INHIBITION; SUPPRESSOR; EXPRESSION; DRIVE;
D O I
10.3390/ijms222212322
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CRISPR/Cas has emerged as an excelle nt gene-editing technology and is used worldwide for research. The CRISPR library is an ideal tool for identifying essential genes and synthetic lethality targeted for cancer therapies in human cancers. Synthetic lethality is defined as multiple genetic abnormalities that, when present individually, do not affect function or survival, but when present together, are lethal. Recently, many CRISPR libraries are available, and the latest libraries are more accurate and can be applied to few cells. However, it is easier to efficiently search for cancer targets with their own screenings by effectively using databases of CRISPR screenings, such as Depmap portal, PICKLES (Pooled In-Vitro CRISPR Knockout Library Essentiality Screens), iCSDB, Project Score database, and CRISP-view. This review will suggest recent optimal CRISPR libraries and effective databases for Novel Approaches in the Discovery and Design of Targeted Therapies.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
    Junwei Shi
    Eric Wang
    Joseph P Milazzo
    Zihua Wang
    Justin B Kinney
    Christopher R Vakoc
    Nature Biotechnology, 2015, 33 : 661 - 667
  • [2] Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
    Shi, Junwei
    Wang, Eric
    Milazzo, Joseph P.
    Wang, Zihua
    Kinney, Justin B.
    Vakoc, Christopher R.
    NATURE BIOTECHNOLOGY, 2015, 33 (06) : 661 - +
  • [3] Functional genomics screening using bacterial cDNA library to discover novel therapeutic modalities for human cancers
    Katoh, Hiroto
    Ishikawa, Shumpei
    CANCER SCIENCE, 2022, 113 : 1564 - 1564
  • [4] Screening the 'receptorome' to discover novel proximal molecular targets of atypical antipsychotic drug actions
    Roth, BL
    Meltzer, HY
    Kroeze, WK
    Evans, JM
    Lopez, E
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 314 - 315
  • [5] Identifying novel therapeutic targets in gastric cancer using genome-wide CRISPR-Cas9 screening
    Zhi Zeng
    Xu Zhang
    Cong-Qing Jiang
    Yong-Gang Zhang
    Xue Wu
    Jin Li
    Shan Tang
    Lang Li
    Li-Juan Gu
    Xiao-Yu Xie
    Ying-An Jiang
    Oncogene, 2022, 41 : 2069 - 2078
  • [6] Identifying novel therapeutic targets in gastric cancer using genome-wide CRISPR-Cas9 screening
    Zeng, Zhi
    Zhang, Xu
    Jiang, Cong-Qing
    Zhang, Yong-Gang
    Wu, Xue
    Li, Jin
    Tang, Shan
    Li, Lang
    Gu, Li-Juan
    Xie, Xiao-Yu
    Jiang, Ying-An
    ONCOGENE, 2022, 41 (14) : 2069 - 2078
  • [7] IDENTIFICATION OF NOVEL TARGETS IN GLIOBLASTOMA STEM CELLS THROUGH CRISPR-CAS9 SCREENING
    Xie, Qi
    Prager, Briana
    Rich, Jeremy
    NEURO-ONCOLOGY, 2017, 19 : 228 - 229
  • [8] Identification of novel drug targets and drug combination using CRISPR screens in cancer
    Yusa, Kosuke
    CANCER SCIENCE, 2018, 109 : 140 - 140
  • [9] Editorial: Utilizing omics strategies to discover new drug targets for cancers
    Zhang, Shujun
    Xue, Chen
    Gu, Xinyu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] DRUG SCREENING AND CRISPR/CAS9 SCREENING OF HCN CHANNELS
    Smieszek, Sandra
    Doldur-Balli, Fusun
    Keenan, Brendan
    Zimmerman, Amber
    Veatch, Olivia
    Polymeropoulos, Christos
    Birznieks, Gunther
    Polymeropoulos, Mihael
    SLEEP, 2024, 47